Want to join the conversation?
$ENDP said that sterile injectables have tripled in net sales since Par acquired JHP in 2104; the company expects continued double digit growth in this segment with GM above the company average in 2016. The company also said that across its generic business, $ENDP expects underlying growth in the mid to high teens in 2016.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.